CELL TYPE-SPECIFIC MECHANISMS REGULATE HEPATITIS B VIRUS TRANSGENE EXPRESSION IN LIVER AND OTHER ORGANS

1996 ◽  
Vol 180 (4) ◽  
pp. 441-449 ◽  
Author(s):  
EMMA ARAGONA ◽  
ROBERT D. BURK ◽  
MICHAEL OTT ◽  
DAVID A. SHAFRITZ ◽  
SANJEEV GUPTA
2004 ◽  
Vol 4 (2) ◽  
pp. 163-167 ◽  
Author(s):  
Tadanori Yamada ◽  
Masakazu Ueda ◽  
Masaharu Seno ◽  
Akihiko Kondo ◽  
Katsuyuki Tanizawa ◽  
...  

2005 ◽  
Vol 25 (17) ◽  
pp. 7522-7533 ◽  
Author(s):  
Zhi-Ming Huang ◽  
Thomas Tan ◽  
Hiderou Yoshida ◽  
Kazutoshi Mori ◽  
Yanjun Ma ◽  
...  

ABSTRACT IRE1-alpha is an integral membrane protein of the endoplasmic reticulum (ER) that is a key sensor in the cellular transcriptional response to stress in the ER. Upon induction of ER stress, IRE1-alpha is activated, resulting in the synthesis of the active form of the transcription factor XBP1 via IRE1-mediated splicing of its mRNA. In this report, we have examined the role of IRE1-alpha and XBP1 in activation of the hepatitis B virus S promoter by ER stress. Cotransfection experiments revealed that overexpression of either IRE1-alpha or XBP1 activated this promoter. Conversely, cotransfected dominant-negative IRE1-alpha or small interfering RNA directed against XBP1 decreased the activation of the S promoter by ER stress, confirming an important role for the IRE1-alpha/XBP1 signaling pathway in activation of the S promoter. However, XBP1 does not bind directly to the S promoter; rather, a novel S promoter-binding complex that does not contain XBP1 is induced in cells undergoing ER stress in an XBP1-dependent manner. This complex, as well as transcriptional activation of the S promoter, is induced by ER stress in hepatocytes but not in fibroblasts, despite the presence of active XBP1 in the latter. Thus, the hepatitis B virus S promoter responds to a novel, cell type-restricted transcriptional pathway downstream of IRE1-alpha and XBP1.


2010 ◽  
Vol 149 (2) ◽  
pp. 162-166 ◽  
Author(s):  
Fang Zhao ◽  
Sheng-qiang Liang ◽  
Yong Zhou ◽  
Ying-li Wang ◽  
Hu Yan ◽  
...  

2001 ◽  
Vol 75 (14) ◽  
pp. 6482-6491 ◽  
Author(s):  
E. Malanchère-Brès ◽  
P. J. Payette ◽  
M. Mancini ◽  
P. Tiollais ◽  
H. L. Davis ◽  
...  

ABSTRACT DNA motifs containing unmethylated CpG dinucleotides within the context of certain flanking sequences enhance both innate and antigen-specific immune responses, due in part to the enhanced production of Th1-type cytokines. Here we explored the ability of CpG-containing oligodeoxynucleotides combined with recombinant hepatitis B surface antigen (HBsAg) to induce Th1 responses in mice that are transgenic for this antigen and that represent a model for asymptomatic hepatitis B virus chronic carriers. This was compared to hepatitis B virus-specific DNA-mediated immunization, which we have previously shown to induce the clearance of the transgene expression product and the down-regulation of hepatitis B virus mRNA in this transgenic mouse lineage. In control nontransgenic C57BL/6 mice, three immunizations with HBsAg and CpG triggered the production of anti-HBs antibodies and of HBs-specific T cells that secrete gamma interferon but do not display any HBsAg-specific cytotoxic activity. In the HBsAg-transgenic mice, immunization with HBsAg and CpG oligodeoxynucleotides, but not with CpG alone, induced the clearance of HBsAg circulating in the sera, with a concomitant appearance of specific antibodies, and was able to regulate the hepatitis B virus mRNA constitutively expressed in the liver. Finally, adoptive transfer experiments with CD8+ T cells primed in C57BL/6 mice with HBsAg and CpG oligodeoxynucleotide-based immunization show that these cells were able to partially control transgene expression in the liver and to clear the HBsAg from the sera of recipient transgenic mice without an antibody requirement. CpG oligodeoxynucleotides motifs combined with HBsAg could therefore represent a potential therapeutic approach with which to treat chronically infected patients.


Virology ◽  
1989 ◽  
Vol 173 (2) ◽  
pp. 764-766 ◽  
Author(s):  
Edward Seto ◽  
Dao-Xiu Zhou ◽  
B. Matija Peterlin ◽  
T.S. Benedict Yen

2019 ◽  
Vol 10 ◽  
Author(s):  
Noriomi Ito ◽  
Kenji Nakashima ◽  
Suofeng Sun ◽  
Masahiko Ito ◽  
Tetsuro Suzuki

1988 ◽  
Vol 8 (6) ◽  
pp. 2449-2455
Author(s):  
T De-Medina ◽  
O Faktor ◽  
Y Shaul

The S promoter, one of the major hepatitis B virus (HBV) promoters, directs the synthesis of mRNA for surface antigen. Transient expression studies revealed that this promoter is highly active in the Alexander hepatoma cell line but not in SK-Hep1 and HeLa cells. We found that a distal element of the promoter (-103 to -48) confers this cell-type-specific behavior through a mechanism in which the promoter activity is repressed in HeLa and SK-Hep1 cells but increased in Alexander cells. By using an inhibitor of protein synthesis, we obtained evidence that a labile repressor(s) confers the negative effect in SK-Hep1 cells. We also found an enhancerlike activity associated with a small DNA segment of the S promoter (-27 to + 30). This proximal element was active in HeLa and SK-Hep1 cells only in the absence of the distal negative element. Finally, analysis of S promoter deletion mutants demonstrated that the -27 to -17 region of the S promoter is crucial for its activity.


Sign in / Sign up

Export Citation Format

Share Document